152 related articles for article (PubMed ID: 11696385)
1. The antibody site in Atlantic salmon; phage display and modeling of scFv with anti-hapten binding ability.
Jørgensen TØ; Solem ST; Espelid S; Warr GW; Brandsdal BO; Smalås A
Dev Comp Immunol; 2002 Mar; 26(2):201-6. PubMed ID: 11696385
[TBL] [Abstract][Full Text] [Related]
2. The primary structure and specificity determining residues displayed by recombinant salmon antibody domains.
Solem ST; Brandsdal BO; Smalås A; Jørgensen TØ
Mol Immunol; 2004 Apr; 40(18):1347-60. PubMed ID: 15072853
[TBL] [Abstract][Full Text] [Related]
3. [Production of phage-displayed anti-idiotypic antibody single chain variable fragments to MG7 monoclonal antibody directed against gastric carcinoma].
He F; Nie Y; Han Z
Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(1):33-6. PubMed ID: 11798849
[TBL] [Abstract][Full Text] [Related]
4. Improvement of anti-Burkholderia mouse monoclonal antibody from various phage-displayed single-chain antibody libraries.
Kim HS; Lo SC; Wear DJ; Stojadinovic A; Weina PJ; Izadjoo MJ
J Immunol Methods; 2011 Sep; 372(1-2):146-61. PubMed ID: 21787781
[TBL] [Abstract][Full Text] [Related]
5. Comparison of fusion phage libraries displaying VH or single-chain Fv antibody fragments derived from the antibody repertoire of a vaccinated melanoma patient as a source of melanoma-specific targeting molecules.
Cai X; Garen A
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9261-6. PubMed ID: 9256470
[TBL] [Abstract][Full Text] [Related]
6. Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1.
Douthwaite JA; Sridharan S; Huntington C; Hammersley J; Marwood R; Hakulinen JK; Ek M; Sjögren T; Rider D; Privezentzev C; Seaman JC; Cariuk P; Knights V; Young J; Wilkinson T; Sleeman M; Finch DK; Lowe DC; Vaughan TJ
MAbs; 2015; 7(1):152-66. PubMed ID: 25484051
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-beta peptide-specific single chain Fv antibodies isolated from an immune phage display library.
Manoutcharian K; Acero G; Munguia ME; Montero JA; Govezensky T; Cao C; Ugen K; Gevorkian G
J Neuroimmunol; 2003 Dec; 145(1-2):12-7. PubMed ID: 14644026
[TBL] [Abstract][Full Text] [Related]
8. Construction, expression, purification, refold and activity assay of a specific scFv fragment against foot and mouth disease virus.
ShengFeng C; Ping L; Tao S; Xin W; GuoFeng W
Vet Res Commun; 2003 Apr; 27(3):243-56. PubMed ID: 12777098
[TBL] [Abstract][Full Text] [Related]
9. Production of phage-displayed anti-idiotypic antibody single chain variable fragments to MG7 monoclonal antibody directed against gastric carcinoma.
Fengtian H; Yongzhan N; Baojun C; Taidong Q; Zheyi H; Daiming F
Chin Med Sci J; 2002 Dec; 17(4):215-9. PubMed ID: 12901508
[TBL] [Abstract][Full Text] [Related]
10. A semi-synthetic repertoire of intrinsically stable antibody fragments derived from a single-framework scaffold.
Desiderio A; Franconi R; Lopez M; Villani ME; Viti F; Chiaraluce R; Consalvi V; Neri D; Benvenuto E
J Mol Biol; 2001 Jul; 310(3):603-15. PubMed ID: 11439027
[TBL] [Abstract][Full Text] [Related]
11. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
[TBL] [Abstract][Full Text] [Related]
12. Lateral recognition of a dye hapten by a llama VHH domain.
Spinelli S; Tegoni M; Frenken L; van Vliet C; Cambillau C
J Mol Biol; 2001 Aug; 311(1):123-9. PubMed ID: 11469862
[TBL] [Abstract][Full Text] [Related]
13. Construction and selection of human anti-idiotypic antibody single chain variable fragments or CDR3 fragments of nasopharyngeal carcinoma.
He X; Li G; Zhu J
J Exp Clin Cancer Res; 2004 Dec; 23(4):607-15. PubMed ID: 15743031
[TBL] [Abstract][Full Text] [Related]
14. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
15. Selection of affinity-improved neutralizing human scFv against HBV PreS1 from CDR3 VH/VL mutant library.
Chen Y; Bai Y; Guo X; Wang W; Zheng Q; Wang F; Sun D; Li D; Ren G; Yin J
Biologicals; 2016 Jul; 44(4):271-275. PubMed ID: 27255707
[TBL] [Abstract][Full Text] [Related]
16. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ
J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353
[TBL] [Abstract][Full Text] [Related]
17. Analysis of antibody selection by phage display utilizing anti-phenobarbital antibodies.
Malone J; Sullivan MA
J Mol Recognit; 1996; 9(5-6):738-45. PubMed ID: 9174966
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the horse V(H) repertoire and comparison with the human IGHV germline genes, and sheep, cattle and pig V(H) sequences.
Almagro JC; Martinez L; Smith SL; Alagon A; Estevez J; Paniagua J
Mol Immunol; 2006 Apr; 43(11):1836-45. PubMed ID: 16337682
[TBL] [Abstract][Full Text] [Related]
19. Effect of VH and VL consensus sequence-specific primers on the binding and neutralizing potential of a single-chain FV directed towards HuIFN-gamma.
Froyen G; Hendrix D; Ronsse I; Fiten P; Martens E; Billiau A
Mol Immunol; 1995 May; 32(7):515-21. PubMed ID: 7783754
[TBL] [Abstract][Full Text] [Related]
20. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
